IL-23/IL-17-induced neutrophil recruitment plays a pivotal role in
rheumatoid arthritis (RA). However, the mechanism of the neutrophil recruitment is obscure. Here we report that
prostaglandin enhances the IL-23/IL-17-induced neutrophil migration in a murine model of RA by inhibiting
IL-12 and IFN gamma production. Methylated BSA (
mBSA) and IL-23-induced neutrophil migration was inhibited by anti-IL-23 and anti-IL-17
antibodies, COX inhibitors,
IL-12, or IFNgamma but was enhanced by
prostaglandin E(2) (
PGE(2)). IL-23-induced
IL-17 production was increased by
PGE(2) and suppressed by COX-inhibition or
IL-12. Furthermore, COX inhibition failed to reduce IL-23-induced neutrophil migration in IL-12- or IFNgamma-deficient mice. IL-17-induced neutrophil migration was not affected by COX inhibitors,
IL-12, or IFNgamma but was inhibited by
MK886 (a
leukotriene synthesis inhibitor), anti-
TNFalpha, anti-CXCL1, and anti-CXCL5
antibodies and by
repertaxin (a CXCR1/2 antagonist). These treatments all inhibited
mBSA- or IL-23-induced neutrophil migration.
IL-17 induced neutrophil chemotaxis through a
CXC chemokines-dependent pathway. Our results suggest that
prostaglandin plays an important role in IL-23-induced neutrophil migration in
arthritis by enhancing
IL-17 synthesis and by inhibiting
IL-12 and IFNgamma production. We thus provide a mechanism for the pathogenic role of the IL-23/IL-17 axis in RA and also suggest an additional mechanism of action for nonsteroidal anti-inflammatory drugs.